News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • VRA shows strong momentum and high free-cash-flow yield despite a sub-1x price-to-sales multiple.
  • Recommended swing trade entry at $5.60 with a stop-loss at $4.80.
  • Mid-term target set at $8.50, implying roughly 52% upside in ~45 trading days.
  • Trade framed as a disciplined long exposure for short-term traders.
  • Valuation gap between FCF yield and P/S multiple underpins the trade rationale.
  • News favors risk-on activity in small-cap retail names this hour.

Latest Articles

Tri Pointe Homes Named to Best Workplaces in Construction List by Great Place To Work and Fortune for the Fifth Consecutive Year

Tri Pointe Homes Named to Best Workplaces in Construction List by Great Place To Work and Fortune for the Fifth Consecutive Year

Tri Pointe Homes has been named one of the Best Workplaces in Construction for the fifth year in a row by Great Place To Work and Fortune. This accolade reflects the company's strong culture, commitment to employee development, and inclusive work environment, reinforcing its leadership position in the U.S. homebuilding industry across 13 states and…

Stryker announces leadership succession

Stryker announces leadership succession

Stryker Corporation announces a planned leadership transition effective January 1, 2027, with current CEO Kevin Lobo moving to Executive Chair of the Board and current President and COO Spencer Stiles becoming the new CEO. The transition follows a comprehensive succession planning process and aims to continue Stryker's growth and innovation as a gl…

BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder

BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder

BullFrog AI disclosed progress in its commercial drug discovery program targeting major depressive disorder for a top 5 global pharmaceutical company. Utilizing its proprietary AI platform, the company successfully identified and prioritized novel neuropsychiatric therapeutic targets, validating its technology and reinforcing its commercial strateg…

Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026

Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026

Galectin Therapeutics announced its participation in the AASLD Liver Meeting 2026 with three presentations highlighting positive trial data of belapectin for treating MASH cirrhosis and portal hypertension. The company also submitted the Phase 3 registrational protocol for belapectin to the FDA, marking a critical step toward developing the first t…

Turning Savings into Security: Canadians Feel on Track for Retirement, But Worry About What Comes Next

Turning Savings into Security: Canadians Feel on Track for Retirement, But Worry About What Comes Next

BlackRock's inaugural Canada Read on Retirement report reveals that while Canadian workers participating in retirement plans are generally confident in their savings progress, many remain uncertain about their long-term retirement security. Key concerns include worries about outliving savings, challenges posed by inflation and market volatility, an…

Fox Deal Supercharges Roku's Ad Play — Buy for the Next 6 Months

Fox Deal Supercharges Roku's Ad Play — Buy for the Next 6 Months

Roku's pending acquisition by Fox Corporation and continued platform growth make the stock an actionable long trade. The deal should expand Roku's content pipeline, boost advertising scale and reduce content churn risks — catalysts that justify taking a long position at current levels ($153.42). Risk-managed entry, stop and target provided for a lo…

Green Circle Decarbonize Technology Planned to Enter AI Data Center Cooling Market with Proprietary Ultra-Low Energy Liquid Cooling Solutions

Green Circle Decarbonize Technology Planned to Enter AI Data Center Cooling Market with Proprietary Ultra-Low Energy Liquid Cooling Solutions

Green Circle Decarbonize Technology Limited (NYSE: GCDT) is expanding into the AI data center infrastructure market by developing next-generation ultra-low energy liquid cooling systems. Utilizing proprietary phase change materials and thermal engineering, the company aims to improve energy efficiency and reduce operational costs in high-density AI…

Suzano: Cheap, Cyclical, and Ready to Reprice If Pulp Margins Recover

Suzano: Cheap, Cyclical, and Ready to Reprice If Pulp Margins Recover

Suzano (SUZ) trades at a modest multiple and yields ~2.16%. The company is levered to hardwood eucalyptus pulp prices and has been active on strategic investments and liability management. If pulp prices normalize from current cyclical levels, SUZ could re-rate toward its 52-week highs; this trade proposes a long with a clear entry, stop and target…

ParaZero and ThirdEye Unveil New Battlefield System Designed to Detect and Intercept Drones for Armored Vehicles

ParaZero and ThirdEye Unveil New Battlefield System Designed to Detect and Intercept Drones for Armored Vehicles

ParaZero Technologies Ltd. has partnered with ThirdEye Systems Ltd. to combine their technologies into a comprehensive counter-UAS system for armored vehicles. The integrated solution pairs ThirdEye's AI-driven Iron Web drone detection technology with ParaZero's DefendAir net-based drone interception system, offering a 360° detect-to-defeat capabil…

Cerenome Launches CNSide® CSF Molecular Profile Tests

Cerenome Launches CNSide® CSF Molecular Profile Tests

Cerenome, Inc. announced the commercial launch of CNSide® CSF Molecular Profile tests for comprehensive DNA and RNA profiling of central nervous system cancers using cerebrospinal fluid. These new tests expand diagnostic capabilities beyond leptomeningeal metastases to include primary CNS tumors and hematologic malignancies, offering clinicians act…

Allied Gold Reports Resource Growth and Mine Life Extension Potential from Exploration Program as the Kurmuk Mine Completes Commissioning and Begins Operations

Allied Gold Reports Resource Growth and Mine Life Extension Potential from Exploration Program as the Kurmuk Mine Completes Commissioning and Begins Operations

Allied Gold Corporation reports significant exploration success at its Kurmuk Mine, with extensions to mineralized zones and discovery of additional higher-grade ore prospects. The commissioning of the Kurmuk Mine is progressing with first ore expected in the grinding circuit imminently. Expanded resource estimates and ongoing exploration along mul…

BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia

BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia

BridgeBio Pharma announced that the FDA has accepted and granted Priority Review to its New Drug Application for oral infigratinib, a targeted therapy for children with achondroplasia. The company’s Phase 3 PROPEL 3 trial demonstrated significant improvements in height velocity, body proportionality, and other health measures, supporting the drug's…

SunPower Breaks Ground on Reno AI Data Center

SunPower Breaks Ground on Reno AI Data Center

SunPower Inc. (Nasdaq: SPWR) has broken ground on a solar power system for an AI data center in Reno, Nevada, marking a strategic expansion into complex commercial solar projects. The project serves as a learning opportunity for the company and aims to enhance its commercial system capabilities under rigorous performance specifications. The CEO hig…